HALO logo
halo search icon
Medicenna Therapeutics Corp.

CA$0.44

Price Change Indicator
-0.025 (-5.319%)
Medicenna Therapeutics Corp.
MDNA · TSE

Medicenna Therapeutics Corp.

Start Trading MDNA for Free

CA$0.44

Price Arrow-0.025 (-5.319%)
20/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueNear SupportVolume Spike
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Medicenna Therapeutics Corp. Overview

MDNA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About MDNA

icon
icon

Telephone

1.416.648.5555

icon

Address

7th floor, 2 Bloor Street West, Toronto, ON M4W 3E2

Description

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.

MDNA Price Chart

Key Stats

Market Cap

CA$32.31M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.45 - 1.97

Trade Value (12mth)

US$15,904.00

1 week

-17.59%

1 month

-24.58%

YTD

-55.5%

1 year

-61.3%

All time high

7.25

Key Fundamentals

EPS 3 yr Growth

-3.40%

EBITDA Margin

0.00%

Operating Cashflow

-$16m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

83m

HALO Sector

Healthcare

Next Company Report Date

25-Jun-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CAD

Short Sell (% of issue)

0.00

MDNA Fundamentals

Per Share Records

Historical data

Forecast data

CAD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.37-0.15-0.15locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.37-0.15N/Alocklocklock
Growth
 %locklocklocklock-135.657.92.6locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Medicenna Therapeutics Corp. (MDNA:TSE)?
Halo FAQ
The current share price of Medicenna Therapeutics Corp. (MDNA:TSE) is CAD$0.44.
What is the 52-week high share price for Medicenna Therapeutics Corp. (MDNA:TSE)?
Halo FAQ
The 52-week high share price for Medicenna Therapeutics Corp. (MDNA:TSE) is CAD$1.97.
What is the 52-week low share price for Medicenna Therapeutics Corp. (MDNA:TSE)?
Halo FAQ
The 52-week low share price for Medicenna Therapeutics Corp. (MDNA:TSE) is CAD$0.45.
What is the dividend yield for Medicenna Therapeutics Corp. (MDNA:TSE)?
Halo FAQ
Medicenna Therapeutics Corp. (MDNA:TSE) does not pay a dividend.
What was Medicenna Therapeutics Corp. (MDNA:TSE) last dividend payment?
Halo FAQ
Medicenna Therapeutics Corp. (MDNA:TSE) does not pay a dividend.
What is the franking level for Medicenna Therapeutics Corp. (MDNA:TSE)?
Halo FAQ
Medicenna Therapeutics Corp. (MDNA:TSE) has a franking level of 0.00%.
In which sector is Medicenna Therapeutics Corp. (MDNA:TSE) classified?
Halo FAQ
Medicenna Therapeutics Corp. (MDNA:TSE) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial